💊
Abraxane
paclitaxel
Nowotwory piersi;Nowotwory trzustki;Rak płuca niedrobnokomórkowy
✅ Upoważniony
✅
Brak aktywnych alertów
Ten lek nie jest objęty bieżącymi niedoborami, listami ostrzegawczymi ani wycofany z rynku.
Do czego to służy
Abraxane monotherapy is indicated for the treatment of metastatic breast cancer in adult patients who have failed first-line treatment for metastatic disease and for whom standard, anthracycline containing therapy is not indicated. Abraxane in combination with gemcitabine is indicated for the first-line treatment of adult patients with metastatic adenocarcinoma of the pancreas. Abraxane in combination with carboplatin is indicated for the first-line treatment of non-small cell lung cancer in adult patients who are not candidates for potentially curative surgery and/or radiation therapy.
⚠️ Bezpieczeństwo pacjenta
No
📚 Poprzednie alerty (2)
Oficjalna strona EMA
https://www.ema.europa.eu/en/medicines/human/EPAR/abraxane